2 Breakout Growth Stocks You Can Buy and Hold for the Next Decade

The article is bullish on MercadoLibre and The Real Brokerage, highlighting accelerating revenue growth of 47% year over year for MercadoLibre and 44% for The Real Brokerage last quarter. MercadoLibre’s $94 billion market cap and $3.2 billion in trailing EBIT are framed as attractive relative to long-term growth potential, despite current margin compression from reinvestment. The Real Brokerage is gaining share with about 32,000 agents and roughly $2 billion in revenue last year, but remains unprofitable with a slight operating loss.

Analysis

The market is still discounting the difference between margin compression caused by reinvestment and margin compression caused by demand deterioration. In both names, the operating profile is being deliberately transformed to widen the moat: one is monetizing logistics + credit depth, the other is trying to convert a fragmented services market into a software-led distribution network. That usually looks expensive until scale inflects, then it re-rates fast because the market realizes the near-term margin hit was the cheapest possible way to buy long-duration growth.

For MELI, the key second-order effect is competitive dislocation: heavier shipping subsidies and broader fintech credit will pressure weaker regional e-commerce players and local payment providers that cannot fund the same customer acquisition intensity. The more important catalyst is not revenue growth itself but the combination of improving delivery reliability and embedded credit, which can expand order frequency and take-rate simultaneously; that is the setup for operating leverage to reassert over the next 4-8 quarters if loss rates stay contained.

For REAX, the real debate is whether its model can compound agent count without collapsing unit economics. If the platform keeps adding agents faster than legacy brokerages can match the economics, incumbent brokerages face a slow bleed of productive agents, which is more damaging than headline share loss because it erodes transaction quality and recruiting leverage. The next 12 months should be watched through agent additions, transaction growth per agent, and whether ancillary services become meaningful enough to offset the still-negative core margin.

The contrarian view is that both stocks may be better businesses than consensus assumes, but the path is likely more volatile than the bull case implies. MELI can remain ‘expensively cheap’ for a long time if credit losses spike or logistics capex stays elevated; REAX can disappoint if growth remains reliant on incentives rather than organic switching. This argues for owning both on pullbacks, but sizing REAX smaller because the business still has more execution risk and less balance-sheet cushion.

Key Decisions for Investors

• Long MELI on weakness over the next 1-3 months; use any post-earnings pullback tied to margin concerns as an entry point, targeting a 12-18 month re-rating if growth stays >30% and operating leverage returns.
• Initiate a smaller long REAX position only if agent growth remains >20% QoQ-equivalent and transaction volume per agent stabilizes; treat as a 6-12 month venture-style compounder with high upside but lower position size due to financing/execution risk.
• Pair trade: long MELI / short a basket of weaker LatAm or regional e-commerce/payment competitors to express moat expansion rather than outright market beta.
• Buy MELI calls 6-9 months out on dips if implied volatility compresses; the convexity is attractive because incremental proof of margin stabilization can trigger a sharp multiple expansion.
• Avoid chasing REAX after sharp momentum spikes; wait for a drawdown or a catalyst window around quarterly agent metrics, since the stock is more likely to trade on operating updates than on narrative alone.